User profiles for S. Roels

staf roels

- Verified email at kuleuven.be - Cited by 7099

Steven M Roels, PhD

- Verified email at abcbirds.org - Cited by 154

PET-based treatment planning in radiotherapy: a new standard?

…, K Haustermans, X Geets, S Roels… - Journal of Nuclear …, 2007 - Soc Nuclear Med
… it may be legitimate to increase the target volume(s) beyond what would have been used with
a … be legitimate to decrease the target volume(s) below what would have been used with a …

[HTML][HTML] Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

…, J Sun, U Tabori, M Kennedy, DS Lieber, S Roels… - Genome medicine, 2017 - Springer
Background High tumor mutational burden (TMB) is an emerging biomarker of sensitivity to
immune checkpoint inhibitors and has been shown to be more significantly associated with …

Co-heating test: A state-of-the-art

G Bauwens, S Roels - Energy and Buildings, 2014 - Elsevier
… ,S represents its negative slope. In order to extract good estimates of both HLC and A sw,S ,
… spread of q sw,s /ΔT with a significant number of data points with low q sw,S /ΔT. The study …

Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors

…, D Khaira, C McMahon, EM Sanford, S Roels… - Cancer discovery, 2015 - AACR
Focal amplification and activating point mutation of the MET gene are well-characterized
oncogenic drivers that confer susceptibility to targeted MET inhibitors. Recurrent somatic splice …

Enhancing agricultural landscapes to increase crop pest reduction by vertebrates

C Lindell, RA Eaton, PH Howard, SM Roels… - Agriculture, Ecosystems …, 2018 - Elsevier
… these questions will increase understanding of the interactions of vertebrate predators and
their prey, the ways in which these interactions provide ecosystem services, and the roles of …

Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib

…, C Mitsiades, B Bryant, F Zhan, WJ Chng, S Roels… - Blood, 2007 - ashpublications.org
The aims of this study were to assess the feasibility of prospective pharmacogenomics
research in multicenter international clinical trials of bortezomib in multiple myeloma and to …

The distribution of BRAF gene fusions in solid tumors and response to targeted therapy

…, SM Ali, JA Elvin, JA Vergilio, S Roels… - … journal of cancer, 2016 - Wiley Online Library
Although the BRAF V600E base substitution is an approved target for the BRAF inhibitors in
melanoma, BRAF gene fusions have not been investigated as anticancer drug targets. In …

Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting

…, S Zhong, M Bailey, JR White, S Roels… - Blood, The Journal …, 2016 - ashpublications.org
The spectrum of somatic alterations in hematologic malignancies includes substitutions,
insertions/deletions (indels), copy number alterations (CNAs), and a wide range of gene fusions; …

Interlaboratory comparison of hygric properties of porous building materials

S Roels, J Carmeliet, H Hens, O Adan… - Journal of thermal …, 2004 - journals.sagepub.com
The precision of methods used for the determination of hygric properties of porous building
materials was investigated. The study was performed in the framework of the EU-initiated …

Assessment method of numerical prediction models for combined heat, air and moisture transfer in building components: benchmarks for one-dimensional cases

…, B Adl-Zarrabi, S Roels… - Journal of thermal …, 2004 - journals.sagepub.com
… system the two phases of water are assumed to be in equilibrium and satisfying Kelvin’s
equation: … heat capacity at constant pressure (J/kg K) g ž density of moisture flow rate (kg/m2 s) …